Your Immune System Is Overactive, Your Genes May Be Why.

Your HLA genes are the immune system’s identity checkpoint. They determine which foreign antigens your T-cells recognize as threats and which ones are safe to ignore. HLA-DQ2 is one of the most common HLA variants, and it’s responsible for presenting antigens to your T-cells in a way that either triggers or suppresses an immune response.

HLA-DQ2 is present in roughly 25-30% of people with European ancestry. Here’s where it becomes a liability: HLA-DQ2 is the primary genetic requirement for celiac disease susceptibility, but it’s also implicated in type 1 diabetes, thyroid autoimmunity, and other systemic autoimmune conditions. If you carry HLA-DQ2 and are exposed to the wrong environmental trigger, your immune system can become licensed to attack your own tissues. The variant itself doesn’t cause disease, but it creates the genetic permission structure for autoimmunity to develop.

What this means for you: if you carry HLA-DQ2, your immune system is primed to mount aggressive responses to specific environmental antigens. That might mean gluten, it might mean a cross-reactive protein, it might mean you’re exquisitely sensitive to infections that others shrug off. You may have unexplained joint pain, recurring sinus infections, or gut inflammation that doctors attribute to IBS rather than immune dysregulation.

CTLA4 is a checkpoint protein on the surface of T-cells. Its job is to apply the brakes when T-cell activation has reached its goal. When a T-cell recognizes an antigen and gets activated, CTLA4 is supposed to send a signal that says, ‘OK, that’s enough. Stand down.’ Without proper CTLA4 function, T-cells remain hyperactive, mounting and sustaining immune responses that should have switched off.

The CTLA4 +49A>G variant is carried by roughly 45% of the population. When you carry the G allele, your CTLA4 protein is less efficient at delivering that shutdown signal, and your T-cells remain more persistently activated. This is why people with this variant often have higher rates of autoimmune disease, chronic activation, and difficulty tolerating even low-level immune stimuli.

You experience this as a hair-trigger immune system. You get sore joints after minor infections. Your inflammatory markers stay elevated longer than they should. You may have developed food sensitivities, environmental sensitivities, or a diagnosis of autoimmune disease that flares unpredictably.

PTPN22 is a phosphatase, an enzyme that removes phosphate groups from proteins involved in T-cell signaling. It acts as a molecular damper, preventing T-cells from becoming overactive. When PTPN22 works properly, it maintains immune tolerance, meaning your T-cells learn to ignore your own tissues and focus only on genuine threats.

The PTPN22 R620W variant (rs2476601) is present in roughly 8-10% of European ancestry populations, but its effect is significant. This variant reduces PTPN22’s ability to suppress T-cell signaling, which shifts the system toward autoimmunity and chronic T-cell activation. People carrying this variant have elevated risk for rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes, and other T-cell driven autoimmune conditions.

At the lived level, PTPN22 variants show up as relentless joint inflammation, persistent antibody elevation, or autoimmune flares that seem to come from nowhere. You may have been told you have seronegative autoimmune disease, or that your antibody panels are just slightly elevated and therefore ‘not significant.’ The significance is in the genetic architecture underlying those elevations.

TNF, or tumor necrosis factor-alpha, is one of the most powerful inflammatory signaling molecules in your body. It’s essential for fighting infections and clearing damaged cells, but when your immune system is dysregulated, TNF becomes a chronic amplifier. TNF triggers a cascade of inflammatory signaling that activates immune cells, increases vascular permeability, and sends your entire inflammatory system into higher gear.

The TNF -308G>A variant is carried by roughly 30% of people with European ancestry. Those who carry the A allele have higher baseline TNF production, meaning their immune system is set to a higher inflammatory thermostat. This is not dramatic in the short term, but over months and years, elevated TNF creates a state of chronic, low-grade systemic inflammation that affects every tissue in your body.

What this feels like: persistent fatigue that rest doesn’t fix, joint and muscle pain without clear cause, brain fog that comes and goes, recurring infections, and difficulty recovering from illness. Your inflammatory markers may be mildly elevated, or they may be normal, because TNF amplifies other inflammatory pathways rather than showing up dramatically on standard testing.

Interleukin-6 is a cytokine that amplifies inflammation and plays a central role in the transition from acute to chronic inflammatory states. Once inflammation starts, IL-6 keeps it going. It crosses the blood-brain barrier, driving neuroinflammation and brain fog. It activates B-cells to produce antibodies. It signals for more immune cells to mobilize. IL-6 is the inflammatory signal that keeps giving.

The IL6 -174G>C variant is carried by roughly 40% of the population who carry the C allele. People with the C allele produce more IL-6 in response to immune triggers, amplifying and extending inflammatory responses that should have resolved. This variant is associated with elevated baseline inflammation, increased infection risk, and higher incidence of both autoimmune disease and age-related inflammatory conditions.

You experience this as inflammation that lingers. You get an infection and feel wiped out for weeks afterward. You have elevated CRP or ESR that your doctor calls ‘chronic inflammation.’ You may have brain fog that correlates with your inflammation flares. Your immune system mounts a response and then forgets how to turn it off.

IRF5 is a transcription factor that controls the expression of interferon and pro-inflammatory cytokines. It’s essential for mounting an immune response to viral infections, but when dysregulated, it drives excessive autoimmune activation and chronic inflammation. IRF5 sits at the intersection of innate immunity and adaptive immunity, meaning it influences both your rapid first-line response and your longer-term antibody production.

IRF5 variants are associated with elevated risk for systemic lupus erythematosus (SLE), rheumatoid arthritis, and primary Sjögren’s syndrome. People carrying IRF5 risk variants mount exaggerated interferon responses and produce more pro-inflammatory cytokines, creating a state of chronic antiviral-like immune activation even in the absence of actual infection. This means your immune system is behaving as if you have a persistent viral threat, even when you don’t.

You experience this as viral-like symptoms that linger, or as autoimmune-like symptoms that doctors can’t quite categorize. You may have elevated interferon signaling markers, you may have autoimmune antibodies that don’t fit a single diagnosis, or you may have a pattern of flares triggered by stress, infection, or environmental exposure.